We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCC icon
2476
Ares Capital
ARCC
$13.9B
$363K ﹤0.01%
19,484
+39
+0.2% +$723
WHG icon
2477
Westwood Holdings Group
WHG
$182M
$362K ﹤0.01%
13,091
+1,049
+9% +$31.9K
NPTN
2478
DELISTED
NEOPHOTONICS CORP
NPTN
$361K ﹤0.01%
59,197
+5,883
+11% +$33.1K
VSLR
2479
DELISTED
VIVINT SOLAR, INC.
VSLR
$361K ﹤0.01%
55,225
-345
-0.6% -$2.73K
DOVA
2480
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$359K ﹤0.01%
12,827
-100
-0.8% -$1.62K
AGEN
2481
Agenus
AGEN
$324M
$358K ﹤0.01%
7,060
-12
-0.2% -$642
IMMR icon
2482
Immersion
IMMR
$255M
$358K ﹤0.01%
46,830
+4,088
+10% +$32.4K
KRYS icon
2483
Krystal Biotech
KRYS
$9.64B
$357K ﹤0.01%
10,270
+1,614
+19% +$72.2K
MCFT icon
2484
MasterCraft Boat Holdings
MCFT
$610M
$357K ﹤0.01%
23,918
-160
-0.7% -$2.61K
GBLI icon
2485
Global Indemnity Group
GBLI
$417M
$356K ﹤0.01%
14,257
+920
+7% +$24.9K
WAAS
2486
DELISTED
AquaVenture Holdings Limited
WAAS
$356K ﹤0.01%
18,324
+2,307
+14% +$41.8K
RCKY icon
2487
Rocky Brands
RCKY
$374M
$355K ﹤0.01%
10,675
+1,000
+10% +$29.8K
CTRN icon
2488
Citi Trends
CTRN
$606M
$354K ﹤0.01%
19,333
+1,375
+8% +$22.3K
RUBY
2489
DELISTED
Rubius Therapeutics, Inc
RUBY
$354K ﹤0.01%
45,058
-215
-0.5% -$2.5K
DOMO icon
2490
Domo
DOMO
$179M
$352K ﹤0.01%
22,017
-15
-0.1% -$362
FOR icon
2491
Forestar Group
FOR
$1.51B
$352K ﹤0.01%
19,234
+1,381
+8% +$27.1K
ADPT icon
2492
Adaptive Biotechnologies
ADPT
$3.91B
$351K ﹤0.01%
+11,369
New +$464K
BCML icon
2493
BayCom
BCML
$335M
$349K ﹤0.01%
15,348
+1,034
+7% +$23.2K
ITIC
2494
Investors Title Co
ITIC
$546M
$349K ﹤0.01%
2,183
+192
+10% +$29.8K
ARQ icon
2495
Arq
ARQ
$88M
$349K ﹤0.01%
23,544
+50
+0.2% +$648
PAR icon
2496
PAR Technology
PAR
$727M
$348K ﹤0.01%
14,628
-85
-0.6% -$2.07K
PHX
2497
DELISTED
PHX Minerals
PHX
$348K ﹤0.01%
24,928
+1,982
+9% +$24.3K
RGCO icon
2498
RGC Resources
RGCO
$226M
$348K ﹤0.01%
11,885
+964
+9% +$27.5K
DF
2499
DELISTED
Dean Foods Company
DF
$348K ﹤0.01%
299,594
+12,919
+5% +$15.3K
SIGA icon
2500
SIGA Technologies
SIGA
$226M
$347K ﹤0.01%
67,817
-450
-0.7% -$2.43K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.